School of Pharmacy

Isabelle Ragueneau-Majlessi

Clinical Professor, Director, UW Drug Interaction Solutions

Department of Pharmaceutics, Pharmaceutics Faculty, School Faculty

Telephone: (206) 543-4669



Accepting Students to Lab: No


  • MD, University of Paris VI
  • Master in Biomedical Regulatory Affairs, University of Washington

Research interests

  • Mechanisms of PK-based drug interactions
  • Regulatory framework of drug interactions assessment
  • Clinical relevance and risk management of drug interactions


Dr. Ragueneau is co-author of the DIDB and e-PKGene applications ( and Director of UW Drug Interaction Solutions. She received her medical degree from St Antoine University in Paris, France, and specialized in Clinical Pharmacology. Prior to moving to the US, Dr. Ragueneau designed and supervised clinical studies in the private sector and in academia for over 6 years. She started working at the University of Washington in 1999, as a Research Associate, then Principal Research Scientist and Project Manager for the Drug Interaction Database. In November 2009, Dr. Ragueneau joined the faculty of the Department of Pharmaceutics as Clinical Associate Professor and was promoted to full Professor in 2014. Dr. Ragueneau has published in the areas of drug-drug interactions (DDIs), drug disposition and clinical pharmacology. She is interested in the regulatory framework of DDI assessment and the clinical relevance of drug interactions. Dr. Ragueneau graduated from the University of Washington’s Master’s Degree Program in Biomedical Regulatory Affairs in 2010. In 2015, she was named a UW CoMotion Presidential Innovation Fellow.

Selected Publications

PubMed link:[Author]%20OR%20ragueneau%20i[Author]